Paper18820
Bone marrow transplantation in the busulfin-treated rat. III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients.
Tutschka PJ and 1 other. Transplantation, 1977. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Bone marrow transplantation in the busulfin-treated rat. III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients. Papers, record 18820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18820
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bone marrow transplantation in the busulfin-treated rat. III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Cells | Major topic |
| Bone Marrow Transplantation | Major topic |
| Busulfan | Major topic |
| Immunosuppression Therapy | Major topic |
| Animals | |
| Antilymphocyte Serum | |
| Cyclophosphamide | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Graft vs Host Reaction | |
| Kinetics | |
| Rabbits | |
| Rats | |
| Rats, Inbred ACI | |
| Rats, Inbred Lew | |
| T-Lymphocytes | |
| Transplantation, Homologous |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31763350 | Immunoresponse to Gene-Modified Hematopoietic Stem Cells. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/31763350 | PubMed |
| 31253582 | Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model. | Mol Ther | 2019 | https://conductscience.org/library/papers/31253582 | PubMed |
| 25066812 | Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome. | J Thromb Haemost | 2014 | https://conductscience.org/library/papers/25066812 | PubMed |
| 20305698 | Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. | Bone Marrow Transplant | 2011 | https://conductscience.org/library/papers/20305698 | PubMed |
| 16543070 | Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. | Exp Hematol | 2006 | https://conductscience.org/library/papers/16543070 | PubMed |
| 14578930 | Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. | Bone Marrow Transplant | 2004 | https://conductscience.org/library/papers/14578930 | PubMed |
| 12774057 | A rat model of syngeneic bone marrow transplantation during breast cancer therapy. | Bone Marrow Transplant | 2003 | https://conductscience.org/library/papers/12774057 | PubMed |
| 12189535 | Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation. | Bone Marrow Transplant | 2002 | https://conductscience.org/library/papers/12189535 | PubMed |
| 11041565 | Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/11041565 | PubMed |
| 10800058 | An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/10800058 | PubMed |
| 10070870 | Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10070870 | PubMed |
| 6377541 | Preparation for bone marrow transplantation. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6377541 | PubMed |
| 2487253 | Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody. | J Invest Surg | 1989 | https://conductscience.org/library/papers/2487253 | PubMed |
| 2122122 | Displacement bone marrow transplantation for some inborn errors. | J Inherit Metab Dis | 1990 | https://conductscience.org/library/papers/2122122 | PubMed |
| 45208 | Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. | Nature | 1979 | https://conductscience.org/library/papers/45208 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18820
GET https://conductscience.org/api/papers/v1/18820/authors